Course and outcome of pregnancy after maternal exposure to angiotensin-II-receptor blockers--case report and review of the literature

Ultraschall Med. 2012 Oct;33(5):493-6. doi: 10.1055/s-0029-1245942. Epub 2011 May 31.
No abstract available

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Angiotensin II Type 1 Receptor Blockers / adverse effects*
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Antihypertensive Agents / adverse effects*
  • Antihypertensive Agents / therapeutic use
  • Breech Presentation
  • Cesarean Section
  • Drug Substitution
  • Female
  • Follow-Up Studies
  • Humans
  • Hypertension / diagnostic imaging
  • Hypertension / drug therapy*
  • Imidazoles / adverse effects*
  • Imidazoles / therapeutic use
  • Infant
  • Infant, Newborn
  • Kidney / drug effects
  • Oligohydramnios / chemically induced
  • Oligohydramnios / diagnostic imaging
  • Olmesartan Medoxomil
  • Pregnancy
  • Pregnancy Outcome*
  • Pregnancy Trimester, First
  • Tetrazoles / adverse effects*
  • Tetrazoles / therapeutic use
  • Ultrasonography, Prenatal

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Imidazoles
  • Tetrazoles
  • Olmesartan Medoxomil